Study S000487

A Pilot Study Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia Post-RYGB

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02685852
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 11
Start: 2016-02
Primary completion: 2019-07-22
Lead sponsor: University of Minnesota
Conditions: Hyperinsulinemic Hypoglycemia
Interventions: DRUG:Exenatide; DRUG:Acarbose; DRUG:Exenatide Placebo; DRUG:Acarbose Placebo
Results posted: FALSE

Registered primary outcomes

Glucose area under the curve (AUC) following treatment for each 4-hour test period [During the 4-hour test period]
Presence of hypoglycemia [15, 30, 45, 60, 90, 120, 180 and 240 minutes]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.